NCT06325488View on ClinicalTrials.gov

Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

June 1, 2026

Conditions
Fabry DiseaseChronic Kidney Diseases
Trial Locations (1)

2100

RECRUITING

Rigshospitalet, Copenhagen

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Caroline Michaela Kistorp

OTHER

NCT06325488 - Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease | Biotech Hunter | Biotech Hunter